An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.

If you're still compounding tirzepatide or semaglutide without meeting patient-specific exceptions, compliance is now mandatory. The enforcement discretion period for both drugs has ended.

Insurance wouldn't cover his weight loss medication. So he started making his own. He's one of thousands looking to the 'gray market' for affordable access to GLP-1 medications.

Thus, the placement of a drug on the drug shortage list allowed compounding pharmacies to compound semaglutide because the FDA did not consider the drug to be “commercially available” in the U.S.

UB researcher Nicole Albanese talks about recent developments, including the end of the shortage of weight-loss drugs and the possible bankruptcy of WeightWatchers.

After the FDA declared a semaglutide shortage in 2022, pharmacies, telehealth companies and other health care providers have been able to manufacture copycat versions of Novo Nordisk‘s GLP-1 ...

Legal wins build on 111 lawsuits filed by Novo Nordisk across 32 states against entities unlawfully marketing and selling compounded "semaglutide" drugs, helping safeguard Americans from knockoffs ...

A U.S. court dismissed a bid by compounding pharmacies to continue to produce copycats of Novo Nordisk’s semaglutide while a lawsuit plays out.

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. A federal ...